GWM
TECH icon

Gitterman Wealth Management’s Bio-Techne TECH Stock Holding History

Gitterman Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,164
Closed -$111K – 307
2025
Q2 		$111K Buy
+2,164
New +$109K 0.03% 236
2022
Q2 		– Sell
-2,164
Closed -$234K – 103
2022
Q1 		$234K Sell
2,164
-2,272
-51% -$234K 0.19% 73
2021
Q4 		$574K Hold
4,436
– – 0.43% 29
2021
Q3 		$538K Sell
4,436
-20
-0.4% -$2.43K 0.43% 27
2021
Q2 		$502K Hold
4,456
– – 0.41% 28
2021
Q1 		$426K Buy
+4,456
New +$407K 0.27% 32

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Gitterman Wealth Management's TECH Position: Q3 2025 in Review

Gitterman Wealth Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 2,164 shares — an estimated $111K sold.

Gitterman Wealth Management first reported a position in TECH in Q1 2021 and held it in 6 quarters. The position peaked at $574K in Q4 2021. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Gitterman Wealth Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Gitterman Wealth Management sold 2,164 Bio-Techne shares in Q3 2025, an estimated $111K.
  • Gitterman Wealth Management first reported a position in Bio-Techne in Q1 2021 and held it in 6 quarters.
  • Gitterman Wealth Management's Bio-Techne position peaked at $574K in Q4 2021.
  • 576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Gitterman Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.